Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation
The coronavirus disease 2019 (COVID-19) has spread widely around the world and has seriously affected the human health of tens of millions of people. In view of lacking anti-virus drugs target to SARS-CoV-2, there is an urgent need to develop effective new drugs. In this study, we reported our disco...
Saved in:
Main Authors: | Ting Xiao (Author), Mengqi Cui (Author), Caijuan Zheng (Author), Ming Wang (Author), Ronghao Sun (Author), Dandi Gao (Author), Jiali Bao (Author), Shanfa Ren (Author), Bo Yang (Author), Jianping Lin (Author), Xiaoping Li (Author), Dongmei Li (Author), Cheng Yang (Author), Honggang Zhou (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
by: Hui-Wen Yang, et al.
Published: (2023) -
Corrigendum: Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
by: Hui-Wen Yang, et al.
Published: (2024) -
Nintedanib Alleviates Experimental Colitis by Inhibiting CEBPB/PCK1 and CEBPB/EFNA1 Pathways
by: Hailong Li, et al.
Published: (2022) -
M10, a Myricetin-3-O-b-D-Lactose Sodium Salt, Prevents Ulcerative Colitis Through Inhibiting Necroptosis in Mice
by: Xiao-Ling Zhou, et al.
Published: (2020) -
Protective Effect of Remdesivir Against Pulmonary Fibrosis in Mice
by: Xiaohe Li, et al.
Published: (2021)